The Science-First Methylene Blue Company
Founded by a serial entrepreneur and an applied chemist, Methylene Blue Ultra bridges the gap between research-grade quality and consumer accessibility.
Our Mission
To deliver USP-grade methylene blue with objective, measurable outcomes through biomarker compatibility — not subjective testimonials.
What We Make
USP 99.9% Purity
Each production batch will be independently verified through GC/MS testing by ISO 17025-accredited laboratories.
TruDiagnostic Compatibility
An MB supplement designed for use alongside epigenetic age tracking (sold separately) — measure your results, not just feel them.
No Staining
Vegetarian capsules eliminate the oral staining associated with troches and liquids.
Clean Formulation
Free from artificial preservatives, gluten, soy, and dairy. Manufactured to cGMP standards.
Company Facts
- Founded
- January 2026
- Headquarters
- Houston, Texas, United States
- Company Type
- For Profit
- Industry
- Dietary SupplementsBiotechnologyHealth and WellnessNutraceuticalLife ScienceE-Commerce
Founders
Alex Bouchard
Co-Founder & CEO
Texas A&M University graduate (Mays Business School, Finance). Serial entrepreneur with a track record spanning digital advertising, professional directory platforms, and commercial real estate. Built and scaled the first-to-market digital advertising partnership network across 47+ core Austin food, beverage, and entertainment venues, along with a multitude of online professional directories. Brokered over half a billion dollars in commercial real estate sales and leasing transactions, with a focus on multi-tenant retail assets. Founded Methylene Blue Ultra to apply the same data-driven, market-gap approach to the rapidly growing longevity supplement space — addressing the significant quality and transparency deficit in the methylene blue market through USP-grade purity standards, third-party verification, and objective biomarker tracking.
Nick Nicotra
Co-Founder & Chief Science Officer
Dynamic leader with over 20 years of experience in the international oil and gas chemical sector, holding leadership positions across seven countries and four continents. Holds a Bachelor of Science in Applied Chemistry with First Class Honors from Curtin University of Technology (thesis: spectro-electrochemistry of pyrites in acidic media) and a Post Graduate Diploma in Business Management with High Distinction from Edith Cowan University. Previously served as Country General Manager and Director of Joint Ventures at ChampionX (formerly Nalco Champion, an Ecolab company) for 16 years, where he managed a $400M contract portfolio and drove over $500M in awarded contracts. Certified in Lean Six Sigma and trained in strategic leadership at Harvard Business School. Recognized with BP's inaugural Ethical Contractor of the Year award (2020) and Nalco Champion Western Hemisphere Area Manager of the Year (2017). Brings deep expertise in applied chemistry, production chemistry, regulatory compliance, operational assurance, and scaling complex technical operations to the supplement industry.
Company Overview
Methylene Blue Ultra is a USP-grade dietary supplement company focused on cognitive support, mitochondrial function, and cellular longevity. Based in Houston, Texas, the company was founded in early 2026 by serial entrepreneur Alex Bouchard and Chief Science Officer Nick Nicotra.
The company's flagship product is a USP 99.9%-purity methylene blue capsule, dosed on the site's flat, product-neutral 5-20mg/day oral schedule rather than a single fixed capsule strength, with each production batch to be independently verified through GC/MS testing by ISO 17025-accredited laboratories. The product is manufactured to cGMP standards in a climate-controlled facility using a vegetarian hypromellose capsule shell with a clean formulation free from artificial preservatives, gluten, soy, and dairy. Certificates of Analysis will be published for each production batch.
Methylene Blue Ultra's central differentiator is its recommended pairing with TruDiagnostic testing (sold separately), an epigenetic testing service that measures biological age through DNA methylation analysis. TruDiagnostic is an independent company not affiliated with Methylene Blue Ultra. The company's MBU Protocol is a structured 90-day regimen that pairs supplementation with pre- and post-testing of biological age markers — designed to give users objective, measurable outcomes rather than relying on subjective self-reporting alone. The protocol follows three phases: baseline biological age testing, a guided titration period, and a re-test at 90 days to quantify changes in epigenetic age.
Methylene blue (methylthioninium chloride) has over 150 years of documented medical use and is FDA-approved as a pharmaceutical for treating methemoglobinemia. As a supplement, it is studied for its role as an alternative electron carrier in the mitochondrial electron transport chain, where it can donate electrons directly to cytochrome c, potentially supporting ATP production and reducing oxidative stress. The company maintains a peer-reviewed research hub referencing 27+ PubMed-indexed studies across cognitive function, Alzheimer's disease research, clinical trials, and longevity science.
The capsule delivery format eliminates the oral staining commonly associated with methylene blue troches and liquids — one of the most frequent consumer complaints in this product category. The company also provides extensive educational resources including a 55-question evidence-based FAQ, a flat-dose calculator with a serotonergic-drug and G6PD safety screen, stacking protocols, and clear safety guidance on drug interactions and contraindications.
Methylene Blue Ultra is currently in a pre-launch phase. The official product launch is targeted for 2026, with founding member pricing and subscribe-and-save options planned at launch.